Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Safety Testing
  • 1.2.3 Purity Testing
  • 1.2.4 Potency Testing
  • 1.2.5 Identity Testing
  • 1.2.6 Stability Testing
• 1.3 Market by Application
  • 1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Precision Therapy
  • 1.3.3 Biological Research
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2016-2027)
• 2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Regions
  • 2.2.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Share by Regions (2016-2021)
  • 2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027)
• 2.3 Cell and Gene Therapy Manufacturing QC Industry Dynamic
  • 2.3.1 Cell and Gene Therapy Manufacturing QC Market Trends
  • 2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
  • 2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
  • 2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
  • 3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2016-2021)
  • 3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2016-2021)
• 3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
• 3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
  • 3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2020
• 3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
• 3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
• 3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type

• 4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2016-2021)
• 4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027)

5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application

• 5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2016-2021)
• 5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
• 6.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type
  • 6.2.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
  • 6.2.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
  • 6.2.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
• 6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application
  • 6.3.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
  • 6.3.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
  • 6.3.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
• 6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
  • 6.4.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
  • 6.4.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
• 7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type
  • 7.2.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
  • 7.2.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
  • 7.2.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
• 7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application
  • 7.3.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
  • 7.3.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
  • 7.3.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
• 7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
  • 7.4.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
  • 7.4.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
• 8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type
  • 8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application
  • 8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
  • 8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
• 9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type
  • 9.2.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
  • 9.2.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
  • 9.2.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
• 9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application
  • 9.3.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
  • 9.3.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
  • 9.3.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
• 9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country
  • 9.4.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
  • 9.4.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
• 10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type
  • 10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application
  • 10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
  • 10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Bio-Techne Corporation
  • 11.1.1 Bio-Techne Corporation Company Details
  • 11.1.2 Bio-Techne Corporation Business Overview
  • 11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
  • 11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.1.5 Bio-Techne Corporation Recent Development
• 11.2 BioMerieux SA
  • 11.2.1 BioMerieux SA Company Details
  • 11.2.2 BioMerieux SA Business Overview
  • 11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
  • 11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.2.5 BioMerieux SA Recent Development
• 11.3 Catalent, Inc.
  • 11.3.1 Catalent, Inc. Company Details
  • 11.3.2 Catalent, Inc. Business Overview
  • 11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
  • 11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.3.5 Catalent, Inc. Recent Development
• 11.4 Charles River Laboratories International Inc.
  • 11.4.1 Charles River Laboratories International Inc. Company Details
  • 11.4.2 Charles River Laboratories International Inc. Business Overview
  • 11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
  • 11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.4.5 Charles River Laboratories International Inc. Recent Development
• 11.5 Eurofins Scientific SE
  • 11.5.1 Eurofins Scientific SE Company Details
  • 11.5.2 Eurofins Scientific SE Business Overview
  • 11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
  • 11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.5.5 Eurofins Scientific SE Recent Development
• 11.6 F. Hoffmann-La Roche Ltd
  • 11.6.1 F. Hoffmann-La Roche Ltd Company Details
  • 11.6.2 F. Hoffmann-La Roche Ltd Business Overview
  • 11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
  • 11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.6.5 F. Hoffmann-La Roche Ltd Recent Development
• 11.7 Intertek Group plc
  • 11.7.1 Intertek Group plc Company Details
  • 11.7.2 Intertek Group plc Business Overview
  • 11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
  • 11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.7.5 Intertek Group plc Recent Development
• 11.8 Lonza Group AG
  • 11.8.1 Lonza Group AG Company Details
  • 11.8.2 Lonza Group AG Business Overview
  • 11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
  • 11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.8.5 Lonza Group AG Recent Development
• 11.9 Merck KGaA
  • 11.9.1 Merck KGaA Company Details
  • 11.9.2 Merck KGaA Business Overview
  • 11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
  • 11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.9.5 Merck KGaA Recent Development
• 11.10 Sartorius AG
  • 11.10.1 Sartorius AG Company Details
  • 11.10.2 Sartorius AG Business Overview
  • 11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
  • 11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.10.5 Sartorius AG Recent Development
• 11.11 SGS S.A.
  • 11.11.1 SGS S.A. Company Details
  • 11.11.2 SGS S.A. Business Overview
  • 11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
  • 11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.11.5 SGS S.A. Recent Development
• 11.12 Sistemic Scotland Limited
  • 11.12.1 Sistemic Scotland Limited Company Details
  • 11.12.2 Sistemic Scotland Limited Business Overview
  • 11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
  • 11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.12.5 Sistemic Scotland Limited Recent Development
• 11.13 Thermo Fisher Scientific Inc.
  • 11.13.1 Thermo Fisher Scientific Inc. Company Details
  • 11.13.2 Thermo Fisher Scientific Inc. Business Overview
  • 11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
  • 11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.13.5 Thermo Fisher Scientific Inc. Recent Development
• 11.14 Vigene Biosciences, Inc.
  • 11.14.1 Vigene Biosciences, Inc. Company Details
  • 11.14.2 Vigene Biosciences, Inc. Business Overview
  • 11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
  • 11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.14.5 Vigene Biosciences, Inc. Recent Development
• 11.15 WuXi AppTec
  • 11.15.1 WuXi AppTec Company Details
  • 11.15.2 WuXi AppTec Business Overview
  • 11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
  • 11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
  • 11.15.5 WuXi AppTec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer